Actively Recruiting
Registry of Aortic Valve Bioprostheses Established by Catheter
Led by French Cardiology Society · Updated on 2025-02-14
5000
Participants Needed
1
Research Sites
1095 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this registry is to evaluate the overall survival up to 10 years of patients with aortic valve bioprostheses implanted via the transarterial or transapical route. Data from the register is enhanced by matching it with continuous data in the SNDS. Mandated by the French health authorities, this registry must be maintained as part of the management of any patient undergoing transarterial or transapical aortic valve bioprosthesis implantation. Participation in the registry is offered to all subjects eligible for bioprosthesis implantation.
CONDITIONS
Official Title
Registry of Aortic Valve Bioprostheses Established by Catheter
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have undergone transarterial or transapical aortic valve bioprosthesis implantation
You will not qualify if you...
- Patient has not given consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Rennes - Pontchaillou
Rennes, France, 35000
Actively Recruiting
Research Team
M
Martine GILARD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here